PL2714042T3 - Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego - Google Patents

Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego

Info

Publication number
PL2714042T3
PL2714042T3 PL12735347T PL12735347T PL2714042T3 PL 2714042 T3 PL2714042 T3 PL 2714042T3 PL 12735347 T PL12735347 T PL 12735347T PL 12735347 T PL12735347 T PL 12735347T PL 2714042 T3 PL2714042 T3 PL 2714042T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
oral administration
analgesic pharmaceutical
analgesic
oral
Prior art date
Application number
PL12735347T
Other languages
English (en)
Inventor
Magdalena BUJALSKA-ZADROŻNY
Marek Naruszewicz
Original Assignee
Warszawski Uniwersytet Medyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warszawski Uniwersytet Medyczny filed Critical Warszawski Uniwersytet Medyczny
Publication of PL2714042T3 publication Critical patent/PL2714042T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL12735347T 2011-05-31 2012-05-31 Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego PL2714042T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL39506911A PL395069A1 (pl) 2011-05-31 2011-05-31 Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego
PCT/PL2012/050016 WO2012165985A1 (en) 2011-05-31 2012-05-31 An analgesic pharmaceutical composition for oral administration
EP12735347.2A EP2714042B1 (en) 2011-05-31 2012-05-31 An analgesic pharmaceutical composition for oral administration

Publications (1)

Publication Number Publication Date
PL2714042T3 true PL2714042T3 (pl) 2019-03-29

Family

ID=46513810

Family Applications (2)

Application Number Title Priority Date Filing Date
PL39506911A PL395069A1 (pl) 2011-05-31 2011-05-31 Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego
PL12735347T PL2714042T3 (pl) 2011-05-31 2012-05-31 Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL39506911A PL395069A1 (pl) 2011-05-31 2011-05-31 Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego

Country Status (7)

Country Link
US (1) US9101577B2 (pl)
EP (1) EP2714042B1 (pl)
DK (1) DK2714042T3 (pl)
ES (1) ES2708689T3 (pl)
HU (1) HUE040419T2 (pl)
PL (2) PL395069A1 (pl)
WO (1) WO2012165985A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2968185A4 (en) * 2013-03-15 2016-08-31 Jaffe Russell M SOFTGELVERKAPSELUNG
GB2607333A (en) * 2021-06-03 2022-12-07 Horopito Ltd Pain relief composition
EP4389120A1 (en) * 2022-12-20 2024-06-26 Inflacod Sp. z o.o. An anti-inflammatory pharmaceutical composition
WO2026033410A1 (en) 2024-08-05 2026-02-12 Vm1 Spolka Z Ograniczona Odpowiedzialnoscia Analgesic dosage form for oral administration with abuse-deterrent properties

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020051794A1 (en) * 2000-08-09 2002-05-02 Alk-Abello A/S Novel parenteral vaccine formulations and uses thereof
US7303759B2 (en) * 2001-06-22 2007-12-04 The United States Of America As Represented By The Secretary Of The Army Compositions and methods for reducing blood and fluid loss from open wounds
KR100972773B1 (ko) * 2001-08-27 2010-07-30 교와 가가꾸고교 가부시키가이샤 제산 ·완하용 정제
US20040048870A1 (en) * 2002-09-06 2004-03-11 Amir Ahmad A. Composition for the prevention and treatment of migraine headaches
MXPA05010821A (es) * 2003-04-08 2006-03-30 Progenics Pharm Inc Terapia de combinacion para constipacion que comprende un laxante y un antagonista opioide periferico.
NZ546183A (en) * 2003-09-26 2011-04-29 Alza Corp Controlled release formulations exhibiting an ascending rate of release
US20080220064A1 (en) * 2006-12-06 2008-09-11 Ramesh Ketkar Anant Extended release matrix formulations of morphine

Also Published As

Publication number Publication date
US20140127302A1 (en) 2014-05-08
US9101577B2 (en) 2015-08-11
DK2714042T3 (da) 2019-01-02
WO2012165985A1 (en) 2012-12-06
EP2714042B1 (en) 2018-08-29
EP2714042A1 (en) 2014-04-09
PL395069A1 (pl) 2012-12-03
ES2708689T3 (es) 2019-04-10
HUE040419T2 (hu) 2019-03-28

Similar Documents

Publication Publication Date Title
IL228709A0 (en) Dosage unit form for oral administration
EP2629786A4 (en) COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS
EP2661273A4 (en) IRON PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION
IL230010B (en) Inhalable pharmaceutical ingredients
PT3653223T (pt) Dispositivo para a entrega oral de compostos terapêuticos
ZA201402669B (en) Solution for oral administration
SG11201400580VA (en) Pharmaceutical composition for inhalation
ZA201105572B (en) Pharmaceutical composition for oral administration
SG11201403875VA (en) Oral pharmaceutical composition
EP2665471A2 (en) Controlled release oral pharmaceutical dosage forms comprising mgbg
EP2618816A4 (en) AEROSOL COMPOSITION FOR THE ADMINISTRATION OF MEDICAMENTS
IL229591A0 (en) Addition of medicine
ZA201306395B (en) New low side effect pharmaceutical composition containing antituberculosis drugs
HUE040419T2 (hu) Analgetikus gyógyászati kompozíció orális beadásra
EP2851074A4 (en) ANALGETIC PHARMACEUTICAL COMPOSITION
IL227651A0 (en) Pharmaceutical formulations for local introduction containing 220b
HU0900482D0 (en) Pharmaceutical formulation for oral administration
EP2979698A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
ZA201205978B (en) Solid pharmaceutical composition for buccal administration of agomelatine
EP2529755A4 (en) PHARMACEUTICAL COMPOSITION AND PREPARATION THEREFOR FOR ORAL ADMINISTRATION
GB201301179D0 (en) Pharmaceutical composition comprising opioid analgesic
ZA201201424B (en) Pharmaceutical dosage form
IL238075A0 (en) pharmaceutical preparations